Agilent Technologies (A) vs Labcorp (LH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Agilent Technologies (A) has outperformed Labcorp (LH) over the past year, gaining 22.0% versus a gain of 11.8%. Over five years, LH leads with a +34.0% price change compared with +10.3% for A. Agilent Technologies is the larger company by market cap ($47.68 billion vs $25.30 billion), about 1.9 times the size, while Labcorp is growing revenue faster (+7.2% vs +6.7%).
On valuation, Labcorp trades at a lower forward P/E (15.7x vs 25.0x for Agilent Technologies). Labcorp offers the higher dividend yield (0.92% vs 0.60%). Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus 6.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | LH |
|---|---|---|
| Share price | $169.09 | $311.97 |
| Market cap | $47.68B | $25.30B |
| 1-day change | -0.14% | +0.08% |
| YTD return | +24.28% | +24.64% |
| 1-year return | +22.05% | +11.83% |
| 5-year return | +10.33% | +34.02% |
| P/E ratio (TTM) | 33.35 | 25.55 |
| Forward P/E | 25.02 | 15.73 |
| EPS (TTM) | $5.07 | $12.21 |
| Dividend yield | 0.60% | 0.92% |
| Annual dividend | $1.01 | $2.88 |
| Revenue (latest FY) | $6.95B | $13.95B |
| Revenue growth (YoY) | +6.73% | +7.25% |
| Net income (latest FY) | $1.30B | $876.50M |
| Gross margin | 52.43% | 28.76% |
| Operating margin | 21.29% | 9.92% |
| Net margin | 18.75% | 6.28% |
| 52-week high | $177.05 | $341.80 |
| 52-week low | $108.35 | $244.52 |
| Distance from 52-week high | -4.50% | -8.73% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +4.38% | +10.33% |
| Average volume | 2.26M | 737.08K |
| Shares outstanding | 281.97M | 81.10M |
| Employees | 18,200 | 71,000 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- A has outperformed LH by 10.2 percentage points over the past year.
- Agilent Technologies trades at a higher earnings multiple (33.4x vs 25.6x trailing P/E).
- Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus 6.3 cents for Labcorp.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Healthcare · Diagnostics & Research · 18,200 employees
About Labcorp
LH stock →Labcorp Holdings Inc. provides laboratory services.
Healthcare · Diagnostics & Research · 71,000 employees
A vs LH FAQ
Which is bigger, Agilent Technologies or Labcorp?
Agilent Technologies (A) is larger, with a market capitalization of $47.68B compared with $25.30B for Labcorp (LH).
Which stock has performed better over the past year, A or LH?
A returned +22.05% over the past 12 months, compared with +11.83% for LH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, A or LH?
LH has the lower trailing P/E at 25.6, versus 33.4 for A. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Agilent Technologies or Labcorp?
Labcorp has the higher yield at 0.92%, compared with 0.60% for Agilent Technologies.
Are Agilent Technologies and Labcorp in the same industry?
Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.